---
schema_version: "secwatch.filing_event.v1"
accession: "0001607062-22-000669"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T20:15:21.420992+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma increases authorized Series A Preferred shares to 739M

## Summary
- Series A Preferred Stock authorized shares increased to 739,000,000 via amendment to Certificate of Designation.
- Amendment to Section 1 of the Certificate of Designation effective November 3, 2022.
- Company presented at Emerging Growth Conference on November 9, 2022; video available via YouTube link.

## SEC filing metadata
- accession: 0001607062-22-000669
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.03, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000669/0001607062-22-000669-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000669/rgbp111022form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001607062-22-000669
- JSON: https://secwatch.observer/filing/0001607062-22-000669.json
- Plain text: https://secwatch.observer/filing/0001607062-22-000669.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.